Literature DB >> 15961383

Energetic mapping of transition state analogue interactions with human and Plasmodium falciparum purine nucleoside phosphorylases.

Andrzej Lewandowicz1, Erika A Taylor Ringia, Li-Min Ting, Kami Kim, Peter C Tyler, Gary B Evans, Olga V Zubkova, Simon Mee, Gavin F Painter, Dirk H Lenz, Richard H Furneaux, Vern L Schramm.   

Abstract

Human purine nucleoside phosphorylase (huPNP) is essential for human T-cell division by removing deoxyguanosine and preventing dGTP imbalance. Plasmodium falciparum expresses a distinct PNP (PfPNP) with a unique substrate specificity that includes 5'-methylthioinosine. The PfPNP functions both in purine salvage and in recycling purine groups from the polyamine synthetic pathway. Immucillin-H is an inhibitor of both huPNP and PfPNPs. It kills activated human T-cells and induces purine-less death in P. falciparum. Immucillin-H is a transition state analogue designed to mimic the early transition state of bovine PNP. The DADMe-Immucillins are second generation transition state analogues designed to match the fully dissociated transition states of huPNP and PfPNP. Immucillins, DADMe-Immucillins and related analogues are compared for their energetic interactions with human and P. falciparum PNPs. Immucillin-H and DADMe-Immucillin-H are 860 and 500 pM inhibitors against P. falciparum PNP but bind human PNP 15-35 times more tightly. This common pattern is a result of kcat for huPNP being 18-fold greater than kcat for PfPNP. This energetic binding difference between huPNP and PfPNP supports the k(chem)/kcat binding argument for transition state analogues. Preferential PfPNP inhibition is gained in the Immucillins by 5'-methylthio substitution which exploits the unique substrate specificity of PfPNP. Human PNP achieves part of its catalytic potential from 5'-OH neighboring group participation. When PfPNP acts on 5'-methylthioinosine, this interaction is not possible. Compensation for the 5'-OH effect in the P. falciparum enzyme is provided by improved leaving group interactions with Asp206 as a general acid compared with Asn at this position in huPNP. Specific atomic modifications in the transition state analogues cause disproportionate binding differences between huPNP and PfPNPs and pinpoint energetic binding differences despite similar transition states.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15961383     DOI: 10.1074/jbc.M505033200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Methylthioinosine phosphorylase from Pseudomonas aeruginosa. Structure and annotation of a novel enzyme in quorum sensing.

Authors:  Rong Guan; Meng-Chiao Ho; Steven C Almo; Vern L Schramm
Journal:  Biochemistry       Date:  2011-01-25       Impact factor: 3.162

2.  Inhibition and structure of Trichomonas vaginalis purine nucleoside phosphorylase with picomolar transition state analogues.

Authors:  Agnes Rinaldo-Matthis; Corin Wing; Mahmoud Ghanem; Hua Deng; Peng Wu; Arti Gupta; Peter C Tyler; Gary B Evans; Richard H Furneaux; Steven C Almo; Ching C Wang; Vern L Schramm
Journal:  Biochemistry       Date:  2007-01-23       Impact factor: 3.162

3.  Altered enthalpy-entropy compensation in picomolar transition state analogues of human purine nucleoside phosphorylase.

Authors:  Achelle A Edwards; Jennifer M Mason; Keith Clinch; Peter C Tyler; Gary B Evans; Vern L Schramm
Journal:  Biochemistry       Date:  2009-06-16       Impact factor: 3.162

4.  Structural and kinetic evidence for an extended hydrogen-bonding network in catalysis of methyl group transfer. Role of an active site asparagine residue in activation of methyl transfer by methyltransferases.

Authors:  Tzanko I Doukov; Hisashi Hemmi; Catherine L Drennan; Stephen W Ragsdale
Journal:  J Biol Chem       Date:  2006-12-15       Impact factor: 5.157

5.  A beta-fluoroamine inhibitor of purine nucleoside phosphorylase.

Authors:  Jennifer M Mason; Andrew S Murkin; Lei Li; Vern L Schramm; Graeme J Gainsford; Brian W Skelton
Journal:  J Med Chem       Date:  2008-09-25       Impact factor: 7.446

Review 6.  Binding isotope effects: boon and bane.

Authors:  Vern L Schramm
Journal:  Curr Opin Chem Biol       Date:  2007-09-14       Impact factor: 8.822

7.  Third-generation immucillins: syntheses and bioactivities of acyclic immucillin inhibitors of human purine nucleoside phosphorylase.

Authors:  Keith Clinch; Gary B Evans; Richard F G Fröhlich; Richard H Furneaux; Peter M Kelly; Laurent Legentil; Andrew S Murkin; Lei Li; Vern L Schramm; Peter C Tyler; Anthony D Woolhouse
Journal:  J Med Chem       Date:  2009-02-26       Impact factor: 7.446

8.  Inhibition and structure of Toxoplasma gondii purine nucleoside phosphorylase.

Authors:  Teraya M Donaldson; María B Cassera; Meng-Chiao Ho; Chenyang Zhan; Emilio F Merino; Gary B Evans; Peter C Tyler; Steven C Almo; Vern L Schramm; Kami Kim
Journal:  Eukaryot Cell       Date:  2014-02-28

9.  L-Enantiomers of transition state analogue inhibitors bound to human purine nucleoside phosphorylase.

Authors:  Agnes Rinaldo-Matthis; Andrew S Murkin; Udupi A Ramagopal; Keith Clinch; Simon P H Mee; Gary B Evans; Peter C Tyler; Richard H Furneaux; Steven C Almo; Vern L Schramm
Journal:  J Am Chem Soc       Date:  2007-12-23       Impact factor: 15.419

Review 10.  Glycosidase inhibition: assessing mimicry of the transition state.

Authors:  Tracey M Gloster; Gideon J Davies
Journal:  Org Biomol Chem       Date:  2009-11-05       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.